These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1278239)

  • 1. BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-beta-hydroxylase with antihypertensive activity.
    Claxton IM; Palfreyman MG; Poyser RH; Whiting RL
    Eur J Pharmacol; 1976 May; 37(1):179-88. PubMed ID: 1278239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine sulfates: end products or metabolic intermediates?
    Demassieux S; Bordeleau L; Gravel D; Carrière S
    Life Sci; 1987 Jan; 40(2):183-91. PubMed ID: 3796219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

  • 6. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive activity of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline (MJ 10459-2) and catecholamine reduction.
    Perhach JL; Gomoll AW
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):155-62. PubMed ID: 1188182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRL 13776: a novel antihypertensive agent with interesting monoamine depleting properties.
    Melrose J; Palfreyman MG; Poyser RH; Whiting RL
    Br J Pharmacol; 1977 Nov; 61(3):357-69. PubMed ID: 588803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of phenylethanolamine N-methyltransferase and dopamine-beta-hydroxylase inhibition on epinephrine levels in the brain.
    Sauter AM; Lew JY; Baba Y; Goldstein M
    Life Sci; 1977 Jul; 21(2):261-6. PubMed ID: 196153
    [No Abstract]   [Full Text] [Related]  

  • 10. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase.
    Stanley WC; Li B; Bonhaus DW; Johnson LG; Lee K; Porter S; Walker K; Martinez G; Eglen RM; Whiting RL; Hegde SS
    Br J Pharmacol; 1997 Aug; 121(8):1803-9. PubMed ID: 9283721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correction of arterial pressure in rats with hereditary hypertension by altering catecholamine metabolism in early ontogeny].
    Naumenko EV; Maslova LN; Markel' AL; Gordienko NI
    Biull Eksp Biol Med; 1987 Oct; 104(10):464-6. PubMed ID: 3676471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asymmetrical content of dopamine-beta-hydroxylase and phenylethanolamine-N-methyltransferase in the adrenals of spontaneously hypertensive and normotensive Wistar-Kyoto rats].
    Hilse H; Oehme P; Hecht K
    Biomed Biochim Acta; 1983; 42(6):745-50. PubMed ID: 6639646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine β-hydroxylase inhibitor.
    Igreja B; Wright LC; Soares-da-Silva P
    J Am Soc Hypertens; 2016 Mar; 10(3):207-16. PubMed ID: 26803288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in hypothalamic catecholamines, dopamine-beta-hydroxylase, and phenylethanolamine-N-methyltransferase in the catfish Heteropneustes fossilis in relation to season, raised photoperiod and temperature, ovariectomy, and estradiol-17 beta replacement.
    Senthilkumaran B; Joy KP
    Gen Comp Endocrinol; 1995 Jan; 97(1):121-34. PubMed ID: 7713376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Substituted picolinic acids as DBH inhibitors. Inhibition of dopamine beta-hydroxylase and antihypertensive action].
    Piesche L; Hilse H; Oehlke J; Schrötter E; Oehme P
    Pharmazie; 1983 May; 38(5):335-8. PubMed ID: 6611632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of phenylethanolamine-N-methyltransferase: effects on brain catecholamine content and blood pressure in DOCA-salt hypertensive rats.
    Liang NY; Chandra A; Tessel RE; Grunewald GL; Borchardt RT
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):319-29. PubMed ID: 6515125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
    Hefti F; Clozel JP; Osterrieder W
    Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol reduces rat dopamine-beta-hydroxylase activity and catecholamine levels.
    Elayan H; Kennedy B; Ziegler MG
    Eur J Pharmacol; 1992 Mar; 212(2-3):259-62. PubMed ID: 1601068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.